These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29200416)

  • 1. Patient-derived tumor xenograft models in drug development.
    Hidalgo M
    Clin Adv Hematol Oncol; 2017 Nov; 15(11):844-846. PubMed ID: 29200416
    [No Abstract]   [Full Text] [Related]  

  • 2. Testing PARP Inhibitors Using a Murine Xenograft Model.
    Makhov P; Naito S; Kolenko VM
    Methods Mol Biol; 2017; 1608():313-320. PubMed ID: 28695518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients.
    Rubio-Viqueira B; Hidalgo M
    Clin Pharmacol Ther; 2009 Feb; 85(2):217-21. PubMed ID: 19005462
    [No Abstract]   [Full Text] [Related]  

  • 4. What's Next for Patient-Derived Xenograft Modeling?
    Gritters J
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 29982758
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer: Xenograft encyclopaedia identifies drug combination opportunities.
    Cully M
    Nat Rev Drug Discov; 2015 Dec; 14(12):818. PubMed ID: 26585532
    [No Abstract]   [Full Text] [Related]  

  • 6. Moving ahead with personalized mouse models.
    Bender E
    Cancer Discov; 2013 Nov; 3(11):1214. PubMed ID: 24203942
    [No Abstract]   [Full Text] [Related]  

  • 7. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
    Gao H; Korn JM; Ferretti S; Monahan JE; Wang Y; Singh M; Zhang C; Schnell C; Yang G; Zhang Y; Balbin OA; Barbe S; Cai H; Casey F; Chatterjee S; Chiang DY; Chuai S; Cogan SM; Collins SD; Dammassa E; Ebel N; Embry M; Green J; Kauffmann A; Kowal C; Leary RJ; Lehar J; Liang Y; Loo A; Lorenzana E; Robert McDonald E; McLaughlin ME; Merkin J; Meyer R; Naylor TL; Patawaran M; Reddy A; Röelli C; Ruddy DA; Salangsang F; Santacroce F; Singh AP; Tang Y; Tinetto W; Tobler S; Velazquez R; Venkatesan K; Von Arx F; Wang HQ; Wang Z; Wiesmann M; Wyss D; Xu F; Bitter H; Atadja P; Lees E; Hofmann F; Li E; Keen N; Cozens R; Jensen MR; Pryer NK; Williams JA; Sellers WR
    Nat Med; 2015 Nov; 21(11):1318-25. PubMed ID: 26479923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preclinical models in oncology].
    Vrignaud P
    Bull Cancer; 2011 Nov; 98(11):1355-61. PubMed ID: 22023796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PET rat model for assessing the effectiveness of new chemotherapies.
    Winnard PT; Sukumar S
    Cancer Biol Ther; 2008 Apr; 7(4):538-9. PubMed ID: 18627116
    [No Abstract]   [Full Text] [Related]  

  • 10. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
    Ruggeri BA; Camp F; Miknyoczki S
    Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity.
    Zhang CC; Yan Z; Zhang Q; Kuszpit K; Zasadny K; Qiu M; Painter CL; Wong A; Kraynov E; Arango ME; Mehta PP; Popoff I; Casperson GF; Los G; Bender S; Anderes K; Christensen JG; VanArsdale T
    Clin Cancer Res; 2010 Nov; 16(21):5177-88. PubMed ID: 20829331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Athymic nude mice as an experimental model for cancer treatment.
    Szadvari I; Krizanova O; Babula P
    Physiol Res; 2016 Dec; 65(Suppl 4):S441-S453. PubMed ID: 28006926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthotopic models of esophageal carcinoma and their use in drug discovery.
    Gros SJ
    Curr Protoc Pharmacol; 2011 Sep; Chapter 14():Unit14.20. PubMed ID: 21898333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
    Merk J; Rolff J; Becker M; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):454-9. PubMed ID: 19502076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Significance of Mouse Models in Lymphoma Research.
    Noble JN; Mishra A
    Curr Hematol Malig Rep; 2019 Apr; 14(2):119-126. PubMed ID: 30848424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Derived Xenograft: An Adjuvant Technology for the Treatment of Metastatic Disease.
    Bousquet G; Janin A
    Pathobiology; 2016; 83(4):170-6. PubMed ID: 27010922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth Inhibition.
    Adiseshaiah PP; Stern ST
    Methods Mol Biol; 2018; 1682():241-253. PubMed ID: 29039107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer].
    Qin B; Jiao X; Yuan L; Liu K; Zang Y
    Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):715-719. PubMed ID: 29061220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening.
    Jung DW; Oh ES; Park SH; Chang YT; Kim CH; Choi SY; Williams DR
    Mol Biosyst; 2012 Jul; 8(7):1930-9. PubMed ID: 22569777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novartis Compiles Mouse Avatar "Encyclopedia".
    Poh A
    Cancer Discov; 2016 Jan; 6(1):5-6. PubMed ID: 26621761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.